Therapeutic Synergy of Picrorhiza kurroa and Piper longum: Mechanistic Perspectives in Hepatoprotection and Liver Disease Management

Abstract

Liver disorders such as Drug-Induced Liver Injury (DILI) and Non-Alcoholic Fatty Liver Disease (NAFLD) represent significant global health concerns. Traditional herbal combinations have long been utilized for their multitarget therapeutic actions; however, the complementary hepatoprotective effects of Picrorhiza kurroa and Piper longum remain inadequately explored. This review evaluates the potential synergistic interactions between these two medicinal plants in the management of liver diseases.

1. kurroa exerts hepatoprotective activity primarily through activation of the Nrf2/ARE antioxidant signaling pathway, suppression of NF-κB-mediated inflammation, and inhibition of TGF-β-driven fibrogenesis. Nevertheless, its therapeutic application is constrained by rapid metabolism and limited bioavailability. P. longum, owing to the presence of piperine, functions as a bioavailability enhancer by inhibiting CYP450 enzymes and P-glycoprotein efflux transporters, thereby improving the systemic availability of picrosides. Additionally, P. longum contributes independent antioxidant and anti-inflammatory properties, further supporting hepatoprotection.

Preclinical evidence indicates that the combined administration of these herbs as a botanical formulation provides greater biochemical and histopathological improvement than either herb used individually. Despite encouraging experimental findings, clinical translation remains restricted due to insufficient standardization of formulations and the scarcity of large-scale randomized controlled trials. Future investigations should focus on mechanistic validation through omics-based approaches, advanced nanotechnology-driven delivery systems, and comprehensive clinical evaluation of the synergistic potential of this herbal combination in the prevention and treatment of chronic liver diseases..